Back to
U.S. Bancorp
ARCT
Showing 8 of 29 quarters
Position history for
U.S. Bancorp's holdings in Arcturus Therapeutics Holdings Inc.
Yes. U.S. Bancorp holds 423 shares of ARCT (Arcturus Therapeutics Holdings), worth $2,843, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. U.S. Bancorp has held ARCT since Q2 2019, across 29 quarterly 13F filings.
Current Value
$2,843
Current Shares
423
Total Value Change
-$22,387
Total Shares Change
-664
Quarter-by-Quarter History